Position in ALNY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$20,771
New position
Shares Held
69
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#134
of 191 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026MCDONALD PARTNERS LLC holds $182,527 across 8 Biotechnology names. ALNY ranks #4 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
211 | $104,810 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
480 | $26,371 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
130 | $24,346 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
69 | $20,771 | |
| 5 | DFTX |
Definium Therapeutics, Inc.
|
66 | $3,104 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
12 | $2,891 | |
| 7 | HELP |
Cybin Inc.
|
26 | $171 | |
| 8 | INO |
Inovio Pharmaceuticals, Inc.
|
58 | $63 |
All Filings in ALNY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,771 | 69 | Shares | Sole | 2026-07-28 | |
| No filing history on record for this holder in this stock. | ||||||